Table 1.
Chemical Assays | End-Point Measure | CGA Isomer | Concentration/Exposure Time | Results | References |
---|---|---|---|---|---|
DPPH assay | DPPH | 5-CQA | 5–80 μM for 3 h | 10%~90% inhibition on DPPH | [51] |
Xanthine/xanthine oxidase system | DMPO/·OOH adducts | 5-CQA | 20 μM for 2.5 min | ↓ 30% ·OOH | [51] |
FeSO4 + H2O2 | DMPO/·OH adducts | 5-CQA | 20 μM for 2.5 min | ↓ 51% ·OH | [51] |
FeSO4 + H2O2 | DMPO/·OH adducts | 5-CQA | 100–400 μM for 1 min | ↓ 50% to 80% ·OH | [52] |
ABTS assay | ABTS·+ | 5-CQA | Serials concentration for 15 min | The ability of 100 g of CGA in scavenging ABTS·+ is equivalent to 3.7 mmol Trolox | [53] |
Rat brain homogenates + sodium nitroprusside | MDA | 5-CQA | 1.56–6.25 μg/mL | No significant inhibition of MDA | [53] |
Liposome system containing AAPH | MDA | 5-CQA | 0.1–0.5 mM | Second order rate of constant of the reactions of LOO· with CGA is 1.28 ± 0.11 × 105 M−1·s−1 | [54] |
Pulse radiolysis to generate O2- | O2- | 5-CQA | 0.2–0.75 mM | Second order rate of constant of the reactions of O2- with CGA is 0.96 ± 0.01 × 106 M−1·s−1 | [54] |
Fenton-type reaction to generate ·OH | ·OH | 5-CQA | 0.1–0.75 mM | Second order rate of constant of the reactions of ·OH with CGA is 3.34 ± 0.19 × 109 M−1·s−1 | [54] |
Potassium phosphate to generate ONOO- | ONOO- | 5-CQA | 80 μM | Second order rate of constant of the reactions of ONOO- with CGA is 1.6 ± 0.7 × 105 M−1·s−1 | [54] |
DPPH assay | DPPH | 3-CQA, | 5 μg/mL–60 μg/mL | EC50 a 3-CQA:13.4 μg/mL | [55] |
4-CQA, | 4-CQA: 13.2 μg/mL | ||||
5-CQA, | 5-CQA: 13.8 μg/mL | ||||
3,5-diCQA, | 3,5-diCQA: 9.3 μg/mL | ||||
3,4-diCQA, | 3,4-diCQA: 9.4 μg/mL | ||||
4,5-diCQA | 4,5-diCQA: 7.5 μg/mL | ||||
ABTS assay | ABTS·+ | 3-CQA | 50 μg/mL–150 μg/mL | EC50 a 3-CQA: 91.4 μg/mL | [55] |
4-CQA, | 4-CQA: 87.5 μg/mL | ||||
5-CQA, | 5-CQA: 91.5 μg/mL | ||||
3,5-diCQA, | 3,5-diCQA: 77.6 μg/mL | ||||
3,4-diCQA, | 3,4-diCQA: 77.4 μg/mL | ||||
4,5-diCQA | 4,5-diCQA: 67.3 μg/mL | ||||
FRAP assay | Reducing power | 3-CQA | 25–125 μg/mL | 4,5-diCQA > 3,5-diCQA > 3,4-diCQA > 5-CQA = 4-CQA = 3-CQA | [55] |
4-CQA, | |||||
5-CQA, | |||||
3,5-diCQA, | |||||
3,4-diCQA, | |||||
4,5-diCQA | |||||
DNA damage protective effect assay | DNA damage | 3-CQA | 50 μg/mL | ↓ 43.1 to 62.4% DNA damage | [55] |
4-CQA, | |||||
5-CQA, | |||||
3,5-diCQA, | 4,5-diCQA > 3,4-diCQA > 3,5-diCQA > 5-CQA > 4-CQA > 3-CQA | ||||
3,4-diCQA, | |||||
4,5-diCQA | |||||
Plasmid pUC18 + NH2Cl | Supercoiled DNA, nicked circular DNA and linear duple | 5-CQA | 0.01 mM–1.23 mM | Prevented a stepwise conversion of plasmid DNA form supercoiled DNA, nicked circular DNA and linear duplex DNA | [50] |
LDL + copper | Conjugated dienes | 5-CQA | 0.25–1.0 μM | ↑ lag time of LDL oxidation | [56] |
LDL + metmyoglobin + H2O2 | ROS | 5-CQA | 1 molar ratio to metmyoglobin | Effectively blocked LDL oxidation | [57] |
a EC50 represents the concentration of the tested compound that results in half-maximal response.